when will retatrutide be approved Retatrutide, an experimental weight-loss drug, has not been by the FDA. But, doctors and nurse practitioners in clinics across the country are prescribing it anyway, a CBS News investigation found. @adamyamaguchi Tirzepatide vs. Retatrutide | AlphaMan

The closest performing GLP-1 medicine in terms of average weight loss is Novo Nordisks CagriSema, an Amylin/GLP-1 dual agonist, which had an average weight loss of 22.7% after 68 weeks in Phase 3 trials

(2024, accessed 4 Apr 2025)

Each time the tirzepatide dose increases , the body needs to readjust to stronger appetite suppression, more pronounced gastric slowing, and faster weight loss

For GLP-1 clinics focused on long-term outcomes, RPM is what turns a prescription service into a care practice

"Berberine may help reduce body weight modestly (about two to four pounds over several weeks) and lower HbA1c levels, but it lacks the robust, consistent results seen with GLP-1 medications like Ozempic, which can produce 15 to 20 percent body weight reductions in clinical trials." Diana Mesa, RDN, LDN, CDCES, founder of En La Mesa Nutrition, agrees, adding that "Berberine does have some similarities [to GLP-1 RA medications] in that it can trigger the pancreas to release insulin and helps make cells more sensitive to the effect of insulin, which is a characteristic similar to what Metformin [another prescription medication prescribed to treat type 2 diabetes and other off-label conditions] does." Still, she notes that it's unclear whether or not Berberine has any appetite-suppressing effects like Ozempic and similar medications

Do side effects prevent faster retatrutide response